GlassScriptPhysician profile
Daniel R Freno
NPI 1700129772
$16,088.31
in general payments reported to CMS, 2019-2025
29 companies · $3,256 in 2025
The $3,256 reported for 2025 was more than what 76% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.66 · 2021: $1,798 · 2022: $8,066 · 2023: $1,632 · 2024: $1,313 · 2025: $3,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,014 · Travel and Lodging: $2,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,013.90 |
| Travel and Lodging | $2,186.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,063.61 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $2,268.82 | 2021-2025 | Endurant Iis, Corevalve Evolut R, Penditure |
| Edwards Lifesciences Corporation | $1,652.23 | 2021-2025 | Evoque, Pascal |
| Abbott Laboratories | $1,330.51 | 2022-2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Atricure, INC. | $937.60 | 2022-2025 | Atriclip Laa Exclusion System |
| Abiomed | $625.22 | 2022-2025 | Impella |
| Inari Medical, INC. | $168.40 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paragonix Technologies, INC. | $162.48 | 2022 | |
| W. L. Gore & Associates, INC. | $111.98 | 2021 | |
| Corcym INC | $100.96 | 2023-2024 | Mi Detach - Aortic Cross Clamp - Delivery System Kit, Perceval |
| Janssen Pharmaceuticals, INC | $99.13 | 2022 | |
| Ethicon US, LLC | $82.92 | 2021-2022 | |
| Endologix LLC | $72.81 | 2024 | Endocross Device, Torus Stent Graft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.74 | 2024-2025 | Lifevest |
| Davol INC. | $45.41 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $38.37 | 2023-2025 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Xl Thrombectomy |
| Chiesi USA, INC. | $36.17 | 2022-2024 | Kengreal, Cleviprex |
| Depuy Synthes Sales INC. | $29.30 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $26.22 | 2022 | |
| Irhythm Technologies, INC. | $22.65 | 2022 | |
| Reflow Medical INC | $22.55 | 2025 | |
| Amgen INC. | $20.74 | 2022 | |
| Cvrx, INC. | $20.38 | 2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $19.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.52 | 2022 | |
| Cagent Vascular INC | $16.34 | 2025 | Serrantor |
| Kls-Martin L.P. | $16.16 | 2022 | |
| Impulse Dynamics (USA) INC. | $15.39 | 2022 | |
| Boston Scientific Corporation | $14.88 | 2025 | Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Freno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.